This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ albendazole,(prescription)

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Antiparasitic Action: Albendazole is a broad-spectrum anthelmintic agent that works by interfering with the microtubule function in the cells of parasites. This leads to disruption of their metabolism, inhibition of glucose uptake, and eventual death of the parasites.

  2. Treatment of Intestinal Worm Infections: Albendazole is used in the treatment of various intestinal worm infections, including:

    • Soil-transmitted helminth infections such as roundworm (Ascaris lumbricoides), hookworm (Ancylostoma duodenale, Necator americanus), and whipworm (Trichuris trichiura).
    • Intestinal tapeworm infections such as Taenia solium (pork tapeworm) and Hymenolepis nana (dwarf tapeworm).
    • Pinworm (Enterobius vermicularis) infections.

  3. Treatment of Tissue Worm Infections: Albendazole is also used in the treatment of certain tissue worm infections, including:

    • Neurocysticercosis: Infection of the central nervous system caused by the larval stage of Taenia solium.
    • Hydatid disease: Infection caused by the larval stage of the Echinococcus tapeworm, leading to the formation of cysts in various organs such as the liver, lungs, and brain.

  4. Dosage and Administration: Albendazole is usually administered orally in the form of tablets or suspension. The dosage and duration of treatment depend on the type and severity of the infection. It is often taken with food to enhance absorption and reduce the risk of gastrointestinal side effects.

  5. Efficacy: Albendazole is highly effective against a wide range of parasitic worms, leading to clearance of the infection and resolution of symptoms in most cases. However, treatment failure or recurrence of infection may occur in some individuals, particularly in areas where reinfection is common or in cases of drug resistance.

  6. Side Effects: Common side effects of albendazole may include gastrointestinal symptoms such as abdominal pain, nausea, vomiting, diarrhea, or constipation. These side effects are usually mild and transient and may resolve with continued use. Allergic reactions such as rash or itching may occur rarely.

  7. Liver Function Monitoring: Albendazole may rarely cause hepatotoxicity (liver damage), particularly at higher doses or with prolonged use. Patients should undergo regular monitoring of liver function tests (e.g., alanine transaminase, aspartate transaminase) during treatment, especially in individuals with pre-existing liver disease.

  8. Contraindications: Albendazole is contraindicated in individuals with known hypersensitivity to the drug or its components. It should be used with caution in pregnant women, as animal studies have shown potential embryotoxic and teratogenic effects. The potential benefits of treatment should be weighed against the risks in pregnant patients.

  9. Drug Interactions: Albendazole may interact with certain medications, including cimetidine, dexamethasone, and praziquantel. Concurrent use should be monitored, and dosage adjustments may be necessary to avoid potential interactions or adverse effects.

  10. Preventive Measures: In addition to treatment with albendazole, preventive measures such as improved sanitation, hygiene practices, and deworming programs may be implemented to reduce the risk of parasitic infections, particularly in endemic areas.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

⚗️ Compensation for antibiotic usage

Data Contradictions — Limits of Certainity

Impacted of albendazole,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Increases
species Akkermansia muciniphila Reduces
species Bifidobacterium adolescentis Increases
species Bifidobacterium animalis Increases
species Bifidobacterium bifidum Increases
species Bifidobacterium breve Increases
species Bifidobacterium catenulatum Increases
species Bifidobacterium longum Increases
species Bifidobacterium pseudocatenulatum Increases
species Bifidobacterium pseudolongum Increases
species Escherichia coli Reduces

Bacteria Impacted by albendazole,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Bifidobacteriaceae family Increases
0 1 Escherichia genus Decreases
0 1 Dorea genus Decreases
0 1 Roseburia genus Decreases
1 0 Wolbachia genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Lachnospira genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Streptococcus genus Decreases
0 1 Blautia genus Decreases
1 0 Akkermansia genus Decreases
1 0 Bifidobacterium genus Increases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 environmental samples no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 unclassified Wolbachia no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 environmental samples no rank Increases
0 1 unclassified Bifidobacterium no rank Increases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Blautia obeum species Decreases
1 0 Roseburia intestinalis species Decreases
1 0 Streptococcus salivarius species Decreases
1 0 Escherichia coli species Decreases
1 0 Ruminococcus bromii species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
0 1 Wolbachia pipientis species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Dorea formicigenerans species Decreases
1 0 Lachnospira eligens species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Bifidobacterium saguini species Increases
0 1 Bifidobacterium pseudolongum species Increases
0 1 Bifidobacterium asteroides species Increases
0 1 Bifidobacterium subtile species Increases
0 1 Bifidobacterium pullorum species Increases
0 1 Bifidobacterium animalis species Increases
0 1 Bifidobacterium scardovii species Increases
0 1 Bifidobacterium imperatoris species Increases
0 1 Bifidobacterium thermophilum species Increases
0 1 Bifidobacterium lemurum species Increases
0 1 Bifidobacterium eulemuris species Increases
0 1 Bifidobacterium dentium species Increases
0 1 Bifidobacterium choerinum species Increases
0 1 Bifidobacterium pseudocatenulatum species Increases
0 1 Bifidobacterium angulatum species Increases
0 1 Bifidobacterium bifidum species Increases
0 1 Bifidobacterium adolescentis species Increases
0 1 Bifidobacterium catenulatum species Increases
0 1 Bifidobacterium actinocoloniiforme species Increases
0 1 Bifidobacterium aesculapii species Increases
0 1 Bifidobacterium avesanii species Increases
0 1 Bifidobacterium biavatii species Increases
0 1 Bifidobacterium bohemicum species Increases
0 1 Bifidobacterium bombi species Increases
0 1 Bifidobacterium boum species Increases
0 1 Bifidobacterium callitrichidarum species Increases
0 1 Bifidobacterium callitrichos species Increases
0 1 Bifidobacterium commune species Increases
0 1 Bifidobacterium coryneforme species Increases
0 1 Bifidobacterium cuniculi species Increases
0 1 Bifidobacterium faecale species Increases
0 1 Bifidobacterium gallicum species Increases
0 1 Bifidobacterium indicum species Increases
0 1 Bifidobacterium magnum species Increases
0 1 Bifidobacterium merycicum species Increases
0 1 Bifidobacterium minimum species Increases
0 1 Bifidobacterium mongoliense species Increases
0 1 Bifidobacterium moukalabense species Increases
0 1 Bifidobacterium myosotis species Increases
0 1 Bifidobacterium porcinum species Increases
0 1 Bifidobacterium psychraerophilum species Increases
0 1 Bifidobacterium reuteri species Increases
0 1 Bifidobacterium ruminantium species Increases
0 1 Bifidobacterium simiae species Increases
0 1 Bifidobacterium stellenboschense species Increases
0 1 Bifidobacterium stercoris species Increases
0 1 Bifidobacterium thermacidophilum species Increases
0 1 Bifidobacterium tissieri species Increases
0 1 Bifidobacterium tsurumiense species Increases
0 1 Bifidobacterium breve species Increases
0 1 Bifidobacterium longum species Increases
0 1 Wolbachieae tribe Decreases

Impact of albendazole,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Acne 0.6 0.6
ADHD 1.1 1.3 -0.18
Age-Related Macular Degeneration and Glaucoma 1.1 1.1
Allergic Rhinitis (Hay Fever) 3.2 1.4 1.29
Allergies 3 2.4 0.25
Allergy to milk products 1.5 0.6 1.5
Alopecia (Hair Loss) 0.7 0.7
Alzheimer's disease 2.4 4 -0.67
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.3 1.5 -0.15
Ankylosing spondylitis 2.4 1.2 1
Anorexia Nervosa 0.7 2.2 -2.14
Antiphospholipid syndrome (APS) 1.3 1.3
Asthma 3.7 2.1 0.76
Atherosclerosis 0.8 1.8 -1.25
Atrial fibrillation 2.2 1.2 0.83
Autism 4.5 4 0.13
Autoimmune Disease 1.5 1.1 0.36
Barrett esophagus cancer 0.3 -0.3
benign prostatic hyperplasia 0.6 0.6
Biofilm 0.7 0.2 2.5
Bipolar Disorder 0.9 0.8 0.13
Brain Trauma 0.9 1.4 -0.56
Breast Cancer 0.5 0.5
Cancer (General) 0.7 0.7
Carcinoma 2.5 1.6 0.56
Celiac Disease 2.5 2.1 0.19
Cerebral Palsy 0.3 1.6 -4.33
Chronic Fatigue Syndrome 2.2 2.4 -0.09
Chronic Kidney Disease 1.8 1.5 0.2
Chronic Lyme 0.5 -0.5
Chronic Obstructive Pulmonary Disease (COPD) 1.3 1.1 0.18
Chronic Urticaria (Hives) 1.3 0.1 12
Coagulation / Micro clot triggering bacteria 1.3 1.3 0
Cognitive Function 1.8 1.4 0.29
Colorectal Cancer 4.5 1.6 1.81
Constipation 1.2 0.7 0.71
Coronary artery disease 1.6 0.7 1.29
COVID-19 3.7 5.6 -0.51
Crohn's Disease 3.6 2.6 0.38
cystic fibrosis 1.9 0.7 1.71
d-lactic acidosis (one form of brain fog) 0.5 0.5
deep vein thrombosis 1.1 1.1 0
Denture Wearers Oral Shifts 0.9 0 0
Depression 5.3 5.6 -0.06
Dermatomyositis 0.9 0.9
Eczema 1.7 1 0.7
Endometriosis 2.1 2.2 -0.05
Eosinophilic Esophagitis 0.3 -0.3
Epilepsy 2.1 0.9 1.33
erectile dysfunction 1.2 1.2
Fibromyalgia 1.9 0.6 2.17
Functional constipation / chronic idiopathic constipation 3.1 2.6 0.19
gallstone disease (gsd) 2.7 0.6 3.5
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0 1.2 0
Generalized anxiety disorder 2.6 0.3 7.67
Glioblastoma 0.3 -0.3
Gout 0.6 0.1 5
Graves' disease 0.9 2.4 -1.67
Gulf War Syndrome 1 0.2 4
Halitosis 0.3 0.3 0
Hashimoto's thyroiditis 2.8 1.5 0.87
Heart Failure 2.3 1 1.3
hemorrhagic stroke 0.6 0.6
Hidradenitis Suppurativa 0.6 0.6
High Histamine/low DAO 1.6 0.3 4.33
hypercholesterolemia (High Cholesterol) 0.5 0.1 4
hyperglycemia 2.9 0.3 8.67
Hyperlipidemia (High Blood Fats) 0.1 0.6 -5
hypersomnia 0.1 -0.1
hypertension (High Blood Pressure 4.5 1.9 1.37
Hypothyroidism 0.7 0.1 6
Hypoxia 2.3 0.6 2.83
IgA nephropathy (IgAN) 1.2 0.6 1
Inflammatory Bowel Disease 3.3 4.4 -0.33
Insomnia 1.6 1.7 -0.06
Intelligence 0.5 0.5
Intracranial aneurysms 0.4 0.4
Irritable Bowel Syndrome 4.3 2.2 0.95
ischemic stroke 1.2 2.2 -0.83
Liver Cirrhosis 4.2 3.5 0.2
Long COVID 2.8 3.6 -0.29
Low bone mineral density 0.8 -0.8
Lung Cancer 0.6 1.1 -0.83
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 1.5 0.3 4
ME/CFS with IBS 0.9 0.7 0.29
ME/CFS without IBS 0.9 0.6 0.5
membranous nephropathy 0.3 0.3
Menopause 0.3 1.3 -3.33
Metabolic Syndrome 4.5 2.8 0.61
Mood Disorders 4.3 3.8 0.13
multiple chemical sensitivity [MCS] 0.9 0.1 8
Multiple Sclerosis 3.3 2.4 0.38
Multiple system atrophy (MSA) 0.9 0.4 1.25
myasthenia gravis 0.9 0.5 0.8
neuropathic pain 0.9 -0.9
Neuropathy (all types) 0.5 1.1 -1.2
neuropsychiatric disorders (PANDAS, PANS) 0.7 0.7
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 4.7 2 1.35
NonCeliac Gluten Sensitivity 0.8 0.6 0.33
Obesity 5.7 4.4 0.3
obsessive-compulsive disorder 3.2 1.7 0.88
Osteoarthritis 1.7 0.6 1.83
Osteoporosis 1.8 1.1 0.64
pancreatic cancer 0.3 0.3 0
Parkinson's Disease 5.6 4 0.4
Polycystic ovary syndrome 3.4 2.3 0.48
Postural orthostatic tachycardia syndrome 0.6 0.6
Premenstrual dysphoric disorder 0.1 0.6 -5
primary biliary cholangitis 0.9 0.3 2
Primary sclerosing cholangitis 0.3 1 -2.33
Psoriasis 1.3 1.3 0
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.8 2.3 0.65
Rosacea 0.9 1.1 -0.22
Schizophrenia 1.7 2.6 -0.53
scoliosis 0.5 0.3 0.67
Sjögren syndrome 1.9 0.7 1.71
Sleep Apnea 1.3 1.6 -0.23
Slow gastric motility / Gastroparesis 1.4 1.4
Small Intestinal Bacterial Overgrowth (SIBO) 1.2 1.2
Stress / posttraumatic stress disorder 2.2 1.3 0.69
Systemic Lupus Erythematosus 1.6 1.3 0.23
Tic Disorder 1.2 0.6 1
Tourette syndrome 0.9 0.9
Type 1 Diabetes 2.8 1.4 1
Type 2 Diabetes 3.8 3.3 0.15
Ulcerative colitis 3.2 1.6 1
Unhealthy Ageing 2.2 0.6 2.67
Vitiligo 1.5 0.7 1.14

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]